Strategic Diagnostics Inc. Announces NPIP Technical Approval And First Commercial Orders For RapidChek(R) SELECT(TM) Salmonella

NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX), today announced that their new RapidChek® SELECT™ Salmonella testing product has been approved by the Technical Committee of the National Poultry Improvement Plan (NPIP) as an analytical method for the detection of Salmonella species in NPIP samples. The method was approved at the NPIP 38th Biennial Meeting held in Portland, Oregon. The Company also announced full commercial adoption of the method by four food processing companies within the first four weeks of commercialization, each with an average annual account value of $50,000.

Back to news